Boston Scientific (NYSE:BSX) is one of today's notable stocks in decline, down 1.9% to $5.67. The S&P is currently trading 0.6% lower to 1,418 and the Dow Jones Industrial Average is trading 0.4% lower to 13,089.
Boston Scientific share prices have moved between a 52-week high of $6.41 and a 52-week low of $4.79 and are now trading 18% above that low price at $5.67 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has remained constant.
Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.
Potential upside of 14.2% exists for Boston Scientific, based on a current level of $5.67 and analysts' average consensus price target of $6.48. The stock should find initial support at its 200-day moving average (MA) of $5.66 and further support at its 50-day MA of $5.45.